Gelteq Limited
GELSNASDAQHealthcareDrug Manufacturers - Specialty & Generic
As of Oct 16, 2026 close
- Market cap
- $4.51M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.39$2.01
- Volume (live)
- -
- Avg. volume (3M)
- 1.30M
Gelteq (GELS) Stock Price & Financial Analysis
Gelteq Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.43 - $0.49 |
|---|---|
| 52-Week High | $2.01 |
| 52-Week Low | $0.39 |
| Open | $0.44 |
| Volume (last close) | 40.20K |
| Average Volume (3M) | 1.30M |
| Revenue (TTM) | 194.73K |
|---|---|
| Net Income (TTM) | -4.92M |
| Free Cash Flow (TTM) | -2.09M |
| EPS (TTM) | −$0.48 |
| Profit Margin | -2526.90% |
| Operating Margin | -941.27% |
| Return on Equity (ROE) | -49.88% |
| Debt to Equity | 0.36 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 4.51M |
|---|---|
| Shares Outstanding | 10.48M |
| Price to Sales (P/S) | 23.18 |
| Price to Book (P/B) | 0.46 |
| EV/EBITDA | -2.18 |
| 50-Day MA | $0.59 |
|---|---|
| 200-Day MA | $0.68 |
| 1-Year Change | −64.70% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Gelteq at a Glance
As of the Oct 16, 2026 close, Gelteq (GELS) has a market capitalization of $4.51M. The stock trades at 23.2× sales. Over the trailing twelve months it lost $4.92M on revenue of $194.73K and burned $2.09M of free cash flow. Revenue grew 84.6% year over year.
As of its latest reported balance sheet, it holds $6.49K in cash and securities against $3.55M of debt, a net debt position of $3.55M.
Gelteq does not currently pay a dividend.
The share price is down 64.7% over the past year. At $0.45 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $0.39 to $2.01, below its 200-day moving average of $0.68.
Frequently Asked Questions About Gelteq
What is the current stock price for GELS?
As of the Oct 16, 2026 close, GELS stock trades at $0.45. The 52-week range is $0.39–$2.01, with a day range of $0.43–$0.49.
What is the P/E ratio for GELS?
The P/E ratio (Price-to-Earnings) for GELS is shown in the Key Statistics section. This valuation metric helps compare Gelteq Limited to industry peers.
Does GELS pay dividends?
Gelteq does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for GELS?
Analyst ratings and recommendations for GELS are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of GELS?
As of the Oct 16, 2026 close, Gelteq's market capitalization is $4.7M, classifying it as a micro-cap company. Gelteq operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.